Los Angeles Talc Verdict: What Johnson & Johnson’s Win Means for Your Claim
You used the powder for years. Maybe decades. You never thought twice about it — it was on the shelf, it was what your mother used, what the doctor recommended keeping the baby dry. Then the diagnosis came: ovarian cancer, or maybe mesothelioma, and somewhere in the research that followed you found the word “talc” connected to the word “cancer,” and the ground shifted under you. Now you read that a jury in Los Angeles just returned a verdict in favor of Johnson & Johnson in a talc case, and you are sitting in a kitchen at 2 a.m. wondering whether that one verdict closed the door on you.
It did not. We will tell you why, in detail, with the law and the evidence and the medicine — because the worst thing that can happen to a person in your position is to give up on a valid claim because one headline made it sound like the fight was over. More than 68,000 talc cases remain pending in the federal multidistrict litigation. Some of the largest plaintiff verdicts in American product liability history have come out of this litigation. And a defense verdict in one courtroom, in front of one jury, on one set of facts, is one data point — not a closing argument.
We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic tort and product liability cases, including talc litigation, and we take California cases working with local counsel where required. This page is our straight assessment of what the Los Angeles verdict means, what California law gives you, and what you need to do — and not do — if you are facing a talc-related cancer diagnosis.
What Happened: The Los Angeles Jury’s Decision
A jury in Los Angeles County — a major venue for product liability and mass tort trials in California — returned a defense verdict in favor of Johnson & Johnson in a talc litigation case related to ovarian cancer. That means the jury was not persuaded, on the specific facts of that case, that the plaintiff had proven that Johnson & Johnson’s talc-based products caused her cancer, or that the company had failed to warn of a risk it knew or should have known about. No damages were awarded. The plaintiff in that case recovered nothing.
That is what a defense verdict is: a finding for the defense on the evidence presented in that trial, in front of that jury, under the procedural posture of that case. It is not a finding that talc is safe. It is not a finding that no talc case can ever be won. It is not a ruling that bars any other plaintiff from filing or pursuing a claim. It is one jury’s response to one set of specific causation evidence — the evidence linking talc exposure to one individual’s cancer — and the defense’s arguments about why that link was not proven.
What the verdict does signal, honestly, is that juries in Los Angeles — a venue historically regarded as plaintiff-friendly in product liability cases — can be receptive to defense arguments about causation in talc cases, particularly where the general scientific question of whether cosmetic talc causes ovarian cancer remains contested. The defense leaned into that uncertainty. The jury agreed with the defense’s characterization. That is a strategic lesson for every plaintiff’s attorney handling these cases, and we will walk through what it means for yours below.
One Verdict Does Not Close the Courthouse Door
The single most important thing to understand is the scale of what is still pending. As of June 2026, the federal multidistrict litigation for Johnson & Johnson talc cases — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, pending before Judge Michael A. Shipp in the District of New Jersey — had 68,029 actions pending. That is not a typo. More than 68,000 individual cases are consolidated in one federal court for pretrial proceedings.
That number exists because thousands of women — and the families of women who have died — filed claims alleging that Johnson & Johnson’s talc-based products caused their ovarian cancer or mesothelioma. The cases come from every state. They involve different plaintiffs, different exposure histories, different diagnoses, different pathology, and different specific causation evidence. A defense verdict in Los Angeles does not dismiss any of them. It does not set a precedent that binds other courts. It does not alter the legal standard. It is one result in one trial.
And the results across this litigation have not all gone one way. In 2018, a Missouri jury returned a $4.69 billion verdict against Johnson & Johnson in a case involving 22 women who alleged talc caused their ovarian cancer. That verdict was reduced on appeal to approximately $2.12 billion by the Missouri Court of Appeals in June 2020. The United States Supreme Court denied certiorari on June 1, 2021, meaning the reduced award stands. That is not a press release — that is a number the highest court in the country let stand, affirmed as reduced, with no further appeal available.
The contrast between a $2.12 billion affirmed plaintiff verdict and a $0 defense verdict tells you the most important thing about this litigation: outcomes are intensely fact-dependent. The same defendant, the same product category, the same general allegations — and juries reach opposite conclusions based on the specific evidence of specific causation in each case. That is why your individual exposure history, your individual diagnosis, and your individual pathology are what matter — not the headline from someone else’s trial.
Johnson & Johnson has also attempted three times to push these cases into a bankruptcy proceeding through a corporate restructuring maneuver sometimes called the “Texas two-step.” The company created a subsidiary — first LTL Management LLC, then Red River Talc LLC — to hold the talc liability and filed Chapter 11 bankruptcy, which would have forced all claims into a court-supervised settlement fund regardless of individual case strength. All three attempts failed. The most recent dismissal came on March 31, 2025, when the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed the Red River Talc Chapter 11, finding vote-solicitation irregularities and impermissible nonconsensual third-party releases. The cases are back in the tort system, where each one stands or falls on its own evidence.
California’s Strict Product Liability Law
California is one of the states whose product liability framework is most favorable to injured consumers. The state applies strict product liability — a doctrine that does not require proving the manufacturer was careless, only that the product was defective and the defect caused the injury.
California applies strict product liability under its landmark product liability jurisprudence, imposing liability on manufacturers for defective products under failure-to-warn, design-defect, and manufacturing-defect theories. California’s substantial-factor test governs causation in toxic tort cases, requiring plaintiffs to prove that exposure to the defendant’s product was a substantial factor in causing the injury.
That blockquote is the framework. Here is what it means in plain English:
Strict liability means Johnson & Johnson does not get to defend by saying “we were careful.” If the product was defective — if it carried a risk the company failed to warn about, or if it was designed in a way that was unreasonably dangerous when a safer alternative existed — and that defect caused your cancer, the company is liable. The focus is on the product, not the company’s state of mind.
Failure to warn is the primary theory in talc cases. The allegation is that Johnson & Johnson knew or should have known that its talc-based products could cause cancer, and that it failed to place an adequate warning on the product or in its marketing. The Los Angeles jury was not persuaded that this failure caused the plaintiff’s cancer — but that is a causation finding, not a rejection of the legal theory itself.
Design defect is the companion theory. The argument is that talc-based powder was defectively designed because safer alternatives existed — cornstarch-based powders, for example — and the company chose to keep selling a product that carried an unnecessary risk.
The substantial-factor test is the causation standard, and it is critical to understanding why some cases win and some lose. California does not require you to prove that talc was the only cause of your cancer, or even the primary cause. You must prove that exposure to the product was a substantial factor in causing the injury. In a toxic tort case, that means presenting evidence — exposure history, pathology, fiber analysis, epidemiological data — that connects your specific cancer to your specific talc use in a way that a jury can find meaningful.
Punitive damages are available in California upon a showing of malice, oppression, or fraud by clear and convincing evidence. If the evidence shows that Johnson & Johnson knew of the cancer risk and concealed or downplayed it, punitive damages — designed to punish and deter, not just compensate — are on the table. The $2.12 billion Ingham verdict included a substantial punitive component.
No cap on compensatory damages. California does not impose a general cap on compensatory damages in product liability cases. That means there is no statutory ceiling on what a jury can award for medical expenses, lost wages, pain and suffering, and other losses — the award is driven by the evidence, not by an arbitrary limit.
Los Angeles County Superior Court routinely handles high-stakes pharmaceutical and consumer product cases. California’s strict liability doctrine, its substantial-factor causation test, its lack of a compensatory damages cap, and its robust consumer protection statutes historically attract mass tort filings. But the defense verdict shows that this framework is plaintiff-friendly in its structure — it does not guarantee a plaintiff outcome. The jury still has to be persuaded on the facts.
General Causation vs. Your Individual Causation
This is the distinction that decides talc cases, and it is the one the Los Angeles jury was wrestling with.
General causation is the question: Can talc cause ovarian cancer in humans? This is a scientific question, answered through epidemiological studies, biological mechanism research, and the consensus (or lack of consensus) among oncologists and toxicologists. The general causation picture for cosmetic talc and ovarian cancer is genuinely contested. Some studies have found a modestly elevated risk associated with perineal talc use. Others have not. The scientific community has not reached the kind of uniform consensus that exists for, say, asbestos and mesothelioma. Johnson & Johnson’s defense teams lean into this uncertainty hard — they bring epidemiologists who testify that the studies are inconsistent, the effect sizes are small, and the biological mechanism is unproven.
Specific causation is the question: Did talc cause your cancer? This is an individual question, answered through your specific exposure history (which products, how often, how many years), your pathology (what type of cancer, what the tissue shows), and the exclusion or weighing of alternative causes (genetic factors, family history, other risk factors). Even where general causation is contested, a strong specific causation case can win — because the jury is not being asked to settle the scientific debate. They are being asked whether this person’s this cancer was more likely than not caused by this exposure.
For mesothelioma cases, the causation picture is dramatically different. Mesothelioma is a cancer of the lining of the lungs or abdomen that is essentially signature to asbestos exposure. Talc deposits are frequently contaminated with asbestos — the two minerals are geologically related and often mined together. If a talc product contained asbestos, and a user developed mesothelioma, the specific causation argument is far stronger because mesothelioma is so closely linked to asbestos that the disease itself points back to the exposure. The latency is long — 20 to 50 years is typical — but the causal chain, when asbestos fibers are found in the product and in the tissue, is powerful.
The Los Angeles verdict was an ovarian cancer case. That matters. The defense’s strongest territory is the ovarian cancer general-causation debate, where the science is most contested. A mesothelioma case against the same defendant, with pathology showing asbestos fibers in the tissue, presents a different evidentiary landscape — one where the defense’s general-causation argument is far weaker.
This is why your individual diagnosis, your individual pathology, and your individual exposure history are what determine whether your case is strong — not the outcome of someone else’s trial.
How a Talc Lawsuit Is Actually Built
Here is how a talc case is assembled, step by step, by a trial team that knows the litigation:
Intake and exposure mapping. The first conversation is about the powder. Which brand? Johnson’s Baby Powder? Shower to Shower? Another talc-based product? How did you use it — daily after showering, on the perineal area, on the body generally? How many years? When did you stop? The exposure history is the foundation, and it has to be specific. “I used some kind of powder for a long time” is a weak foundation. “I used Johnson’s Baby Powder daily on my perineal area from 1975 to 2010” is a strong one.
Medical records and diagnosis timeline. When were you diagnosed? What type of cancer — epithelial ovarian cancer, serous carcinoma, another histological type? What was the stage at diagnosis? What treatment have you undergone — surgery, chemotherapy, radiation? What is your current status? The medical records establish the injury and its severity, and they drive the damages calculation.
Pathology specimens and fiber analysis. This is where specific causation lives. If pathology tissue from your surgery or biopsy is available, it can be analyzed for talc particles and, in mesothelioma cases, for asbestos fibers. Talc particles can be identified in ovarian tissue through specialized pathology techniques. Asbestos fibers can be identified through electron microscopy. The presence of talc or asbestos fibers in your tissue — fibers that match the product you used — is the most powerful specific causation evidence you can present. These pathology blocks must be preserved. If the hospital still has them, a preservation demand goes out immediately. If they have been destroyed under the hospital’s retention policy, the case is weaker — which is why acting early matters.
Product identification. Which specific product did you use? Do you have any containers, boxes, or receipts? Can family members corroborate the brand and the duration of use? Product identification ties your exposure to the specific defendant. In the talc MDL, internal Johnson & Johnson documents showing the company’s own testing and research into talc safety are available through discovery — but your ability to use them depends on proving that you used their product.
Expert witness selection. Talc cases are expert-driven. The plaintiff’s team typically presents epidemiologists (to address general causation), oncologists (to address the diagnosis and treatment), pathologists (to address the tissue findings), and fiber analysts (to identify talc or asbestos in the tissue). In California, expert testimony must satisfy the state’s admissibility standards — the Kelly-Frye test for novel scientific evidence, and the Sargon standard for expert reasoning. The defense will challenge every expert. The selection, preparation, and qualification of your experts is one of the most important decisions in the case.
Discovery and corporate documents. Through the MDL and individual discovery, internal Johnson & Johnson documents are available — testing memos, safety research, marketing decisions, communications about talc and asbestos contamination, and the company’s knowledge of potential cancer risks over decades. These documents are the backbone of the failure-to-warn and punitive damages theories. They show what the company knew and when — which is the difference between a case about a product that turned out to be dangerous and a case about a company that knew its product was dangerous and sold it anyway.
Johnson & Johnson: The Defendant Behind the Powder
Johnson & Johnson is not a single entity you can point at. It is a corporate structure, and understanding that structure is part of understanding where the money is and who is responsible.
The parent company is Johnson & Johnson, a New Jersey-based multinational that sits at the intersection of pharmaceuticals, medical devices, and consumer health. The talc products at issue — primarily Johnson’s Baby Powder and Shower to Shower — were historically sold through Johnson & Johnson Consumer Inc. (JJCI), the consumer products subsidiary.
In 2023, Johnson & Johnson spun off its consumer health business into a separate publicly traded company called Kenvue Inc. — which now owns brands like Band-Aid, Tylenol, and Listerine. Johnson & Johnson retained indemnity obligations related to talc litigation, meaning the parent company — not Kenvue — is the entity that answers for the talc liability. The corporate restructuring was a business decision that separated the consumer brands from the pharmaceutical and device operations, but the talc liability stayed with J&J.
The company has also attempted to use bankruptcy as a litigation management tool. Through a process sometimes called the “Texas two-step,” J&J created a subsidiary — first LTL Management LLC, then Red River Talc LLC — to hold the talc liability, then filed that subsidiary for Chapter 11 bankruptcy. The strategy was designed to force all 68,000+ claims into a single court-supervised settlement fund, capping the company’s exposure and bypassing the individual tort system. Three times the courts rejected this approach. The March 31, 2025 dismissal of Red River Talc’s Chapter 11 by the U.S. Bankruptcy Court for the Southern District of Texas was the third and most recent failure. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases — meaning the company tried to use the bankruptcy to release claims without the claimants’ consent, and the court would not allow it.
The talc supplier Imerys Talc America has also been named in related litigation, as the company that sourced and processed the talc used in J&J’s products. Imerys filed its own bankruptcy in 2019 and established a trust to resolve talc claims.
Meanwhile, Johnson & Johnson continues to expand its oncology drug pipeline — the same news cycle that reported the Los Angeles defense verdict also reported positive European regulatory developments for J&J’s multiple myeloma therapy Tecvayli and the acquisition of Firefly Bio to expand the company’s cancer drug portfolio. The company is simultaneously building a business around treating cancer and defending allegations that its products caused cancer. That juxtaposition is not legal evidence — but it is context for understanding the scale and complexity of the defendant you would be facing.
The coverage reality is that Johnson & Johnson is a balance-sheet defendant. This is not a small company with a thin insurance policy. J&J is one of the largest pharmaceutical companies in the world, with the resources to fund a defense of unlimited duration and complexity. That means the case has to be built right — because the company can outlast a poorly prepared opponent. It also means that when the case is built right and the evidence is strong, the recovery potential is substantial, because the defendant has the resources to pay what a jury awards.
The Evidence Clock: What Exists and How Fast It Disappears
Talc cases are different from car crash cases. There is no skid mark to photograph, no truck to impound, no dashcam to pull. But evidence still exists, and it still deteriorates — on a clock that is measured in years, not days, but a clock nonetheless.
Pathology tissue blocks. If you had surgery for ovarian cancer — an oophorectomy, a debulking procedure, a biopsy — the hospital pathology department preserved tissue blocks from that procedure. Those blocks are the single most important piece of specific causation evidence in a talc case. They can be analyzed for talc particles and, in mesothelioma cases, for asbestos fibers. Hospitals operate on fixed medical-records retention schedules. In California, hospitals generally must retain medical records for a minimum period that varies by facility type and patient status — but pathology blocks may be retained longer than the general medical record. The problem is that retention is not indefinite, and a preservation demand from a lawyer is what converts a routine destruction schedule into a legal obligation to keep the evidence. The day you call a lawyer is the day that demand goes out.
Talc product containers and packaging. If you still have the actual bottle or box of powder you used, that is physical evidence that can be tested for asbestos contamination and talc composition. Product containers sitting in a bathroom cabinet or a storage box are evidence that literally proves product identification. Do not throw them away. Do not let anyone talk you into disposing of them.
Medical records. Your complete medical record — diagnosis, treatment, pathology reports, imaging, physician notes — is the proof of injury and the foundation of the damages calculation. These records exist at multiple providers (your oncologist, your surgeon, your hospital, your imaging center) and must be requested from each. The longer you wait, the more likely some records have been archived, moved to off-site storage, or in the case of older records, destroyed under retention schedules.
JNJ internal corporate documents. Through the MDL and individual discovery, internal Johnson & Johnson documents are available — decades of testing, safety research, marketing decisions, and communications about talc and cancer risk. These documents are subject to existing discovery orders and litigation holds in the MDL, meaning they should be preserved. But accessing them requires active participation in the litigation — they are not handed to you because you ask nicely.
Exposure history from family and friends. Your memory of which products you used, how often, and for how long is critical — but memory fades, and so does the memory of family members who can corroborate. Spouses, children, siblings, and friends who can testify “she used Johnson’s Baby Powder every day after her shower for thirty years” are witnesses whose accounts become less precise with each passing year. Documenting their recollections early — in writing, recorded, or through a formal statement — preserves that evidence before it degrades.
The Defense Playbook and How We Counter Each Move
Johnson & Johnson’s defense teams are among the most experienced in the world. They have tried these cases dozens of times. They know what works. Here are the plays they run, and here is how each one is countered:
Play 1: “The science doesn’t prove talc causes ovarian cancer.” The defense brings epidemiologists who testify that the studies linking talc to ovarian cancer are inconsistent, the effect sizes are small, confounding factors were not adequately controlled, and no biological mechanism has been proven. This is the play that worked in Los Angeles.
Counter: General causation does not have to be unanimous to support a plaintiff verdict. Epidemiological studies showing elevated risk, biological plausibility research, the IARC classification of perineal talc use as possibly carcinogenic, and the company’s own internal research acknowledging potential risk — these together can support a finding that talc can cause ovarian cancer, even if the scientific community has not reached consensus. The substantial-factor test does not require scientific certainty. It requires a jury’s reasonable conclusion that exposure was a substantial factor. The counter is to present the strongest available epidemiological evidence, the biological mechanism research, and — critically — the company’s own internal documents showing it was studying the risk decades ago. The Ingham jury heard this evidence and returned $4.69 billion. The Los Angeles jury heard a version of it and returned nothing. The difference was in the specific evidence and the specific presentation — which is why expert selection and case preparation are everything.
Play 2: “Your cancer came from something else.” The defense argues that ovarian cancer has many risk factors — age, family history, BRCA mutations, nulliparity, endometriosis, hormone therapy — and that the plaintiff’s cancer was more likely caused by one of those than by talc. This is the alternative-causation attack, and it is particularly effective when the plaintiff has a known risk factor.
Counter: The substantial-factor test does not require talc to be the only cause. It requires talc to be a substantial factor. A woman who had a family history of ovarian cancer and used talc daily for 30 years does not have her case erased by the family history — she has two risk factors, and the question is whether talc was a substantial contributing factor. The counter is to present the exposure evidence, the pathology findings (talc particles in tissue, if present), and the dose-response relationship — how much, how often, how long — alongside the alternative risk factors, and let the jury weigh them together. The defense wants the jury to think in either/or terms. The law allows both/and.
Play 3: “The bankruptcy should handle this.” Though three bankruptcy attempts have failed, the company may try again — or may use the threat of another bankruptcy filing to push individual plaintiffs toward low settlements. The message is: “Take what we’re offering now, because if we file bankruptcy again, you’ll get less.”
Counter: Three courts have rejected this strategy. The bankruptcy courts found vote-solicitation irregularities and impermissible nonconsensual third-party releases. The legal landscape for another attempt is unfavorable. The counter is to refuse to be pressured by a strategy that has failed three times and to proceed with the individual case on its own timeline and merits. A case that is strong on its specific evidence does not need to settle for a fraction of its value because of a bankruptcy threat that the courts have repeatedly shut down.
Play 4: “The statute of limitations has expired.” The defense argues that the plaintiff knew or should have known about the talc-cancer connection years ago and waited too long to file. This is a procedural attack that can kill a case before it reaches a jury.
Counter: California’s discovery rule means the clock starts when you knew or should have known of the injury and its cause. For many women, the connection between talc and cancer was not something they had reason to know until media coverage, scientific publications, or the MDL publicity brought it to public attention. The counter is to establish, through your own testimony and the timeline of public awareness, when you first learned that talc might have caused your cancer — and to file before that clock runs out. This is why speaking with a lawyer early is critical: the difference between a timely and an untimely filing can be months.
The Medicine: Ovarian Cancer, Mesothelioma, and Talc
Ovarian cancer is a malignancy that begins in the ovaries or the fallopian tubes. The most common form is epithelial ovarian cancer, which accounts for roughly 90% of cases. The disease is often diagnosed at a late stage because early symptoms — bloating, pelvic pain, urinary urgency — are nonspecific and easily attributed to other causes. By the time many women are diagnosed, the cancer has spread beyond the ovaries, and the prognosis is serious. Five-year survival rates vary by stage at diagnosis, but for advanced-stage disease, they are sobering.
The talc-ovarian cancer hypothesis is based on the theory that talc particles applied to the perineal area can travel through the vagina, uterus, and fallopian tubes to the ovaries, where chronic inflammation from the foreign particles may promote cancer development. Epidemiological studies have produced mixed results — some showing a modestly elevated risk, others showing no statistically significant association. The biological mechanism is plausible but not definitively proven. This contested science is exactly what the defense exploits, and it is why ovarian cancer talc cases are harder to win than mesothelioma talc cases.
Mesothelioma is a cancer of the mesothelium — the thin tissue that lines the lungs, the chest wall, the abdomen, and other organs. It is almost exclusively caused by asbestos exposure. When talc deposits are contaminated with asbestos — and historical testing of some cosmetic talc products has found asbestos contamination — the talc product becomes an asbestos delivery vehicle. A person who used asbestos-contaminated talc powder for years and later developed mesothelioma has a far stronger specific causation case than an ovarian cancer plaintiff, because mesothelioma is so signature to asbestos that the disease itself is near-conclusive evidence of exposure.
The latency for mesothelioma is 20 to 50 years — most often 30 to 40 years. A person exposed to contaminated talc in their twenties may not develop mesothelioma until their sixties. The latency for talc-associated ovarian cancer is less precisely established, but the exposure-to-diagnosis interval is typically measured in decades. This long latency is why the discovery rule is so important — and why the statute of limitations does not start on the day you used the powder, but on the day you knew or should have known the powder caused your cancer.
The proof problem in ovarian cancer cases is that the defense can point to alternative causes and contested general causation. The proof problem in mesothelioma cases is establishing that the specific talc product the plaintiff used was contaminated with asbestos — which requires product testing, historical records, and sometimes identification of the mine or processing facility that sourced the talc. Both are winnable, but they require different evidence and different expert presentations.
What a Talc Case Is Worth
Let us be honest about the numbers, because honesty is what protects you.
The Los Angeles case was worth $0 to the plaintiff. That is what a defense verdict means. No damages were awarded. The plaintiff’s case, on its specific evidence, in front of that jury, did not persuade. That is the truth, and pretending otherwise would be a disservice.
The Ingham verdict in Missouri was worth approximately $2.12 billion — affirmed. That was a case involving 22 plaintiffs who alleged talc caused their ovarian cancer. The jury awarded $4.69 billion. The Missouri Court of Appeals reduced it to approximately $2.12 billion. The United States Supreme Court denied certiorari on June 1, 2021, meaning the reduced award is final. That is not a projection or a promise — it is a matter of public record, a verdict the highest court in the country allowed to stand.
Individual case values across the talc litigation have ranged widely — from defense verdicts like the one in Los Angeles, to individual plaintiff verdicts in the millions, to the aggregate $2.12 billion Ingham award. The range exists because case value is driven by specific facts:
- Diagnosis type. Mesothelioma cases typically carry higher values than ovarian cancer cases because the causation is stronger and the disease is more uniformly fatal.
- Exposure history. Duration, frequency, and method of use (perineal application vs. general body use) affect both causation strength and damages.
- Pathology evidence. The presence of talc particles or asbestos fibers in tissue is powerful specific causation evidence that can drive verdict value up.
- Punitive damages exposure. Where internal corporate documents show the company knew of the risk and concealed it, punitive damages become available — and in California, there is no cap on punitive damages in product liability cases (though the U.S. Supreme Court has imposed constitutional limits on the ratio of punitive to compensatory damages).
- Age and earning capacity. A younger plaintiff with more lost earning years and more future medical needs carries a higher economic damages calculation.
- Jurisdiction. California’s favorable product liability framework, lack of a compensatory damages cap, and substantial-factor causation test make it a relatively favorable venue — but as the Los Angeles verdict shows, favorable law does not guarantee a favorable outcome.
Damages categories in a talc case include:
- Economic damages: past and future medical expenses (surgery, chemotherapy, radiation, ongoing monitoring), lost wages, loss of earning capacity, home care and assistance, transportation to treatment.
- Non-economic damages: pain and suffering, emotional distress, loss of quality of life, loss of enjoyment of activities, physical disfigurement, the psychological impact of a cancer diagnosis and treatment.
- Punitive damages: available upon a showing of malice, oppression, or fraud by clear and convincing evidence — designed to punish the defendant and deter similar conduct.
- Wrongful death damages: if the plaintiff has died, the surviving family may recover for loss of financial support, loss of companionship, funeral expenses, and the decedent’s pain and suffering prior to death through a survival action.
Past results depend on the facts of each case and do not guarantee future outcomes. The Ingham verdict and the Los Angeles defense verdict are both real, both final, and both tell you the same thing: your case will be won or lost on its own evidence.
Your Deadline: California’s Statute of Limitations
California’s personal injury statute of limitations — the law that sets the deadline to file a lawsuit — generally gives you two years from the date you discovered, or should have discovered, your injury and its cause. For latent diseases like cancer that may appear decades after exposure, California applies the discovery rule: the clock does not start on the day you used the talc powder. It starts on the day you knew or should have known that your cancer was caused by talc.
This is a critical protection for talc plaintiffs, because the latency between exposure and diagnosis is measured in decades. A woman who used talc powder from 1975 to 2000 and was diagnosed with ovarian cancer in 2023 may not have had any reason to connect her cancer to talc until media coverage, scientific publications, or legal filings brought the connection to public attention. Under the discovery rule, her two-year clock may have started when she learned of the connection — not when she stopped using the powder in 2000.
But the discovery rule is not unlimited. Some states impose an outer deadline — a statute of repose — that can cut off a claim even before discovery. And the “should have known” standard means the defense will argue that you had reason to know earlier than you claim. The date you first learned of the talc-cancer connection, the date you were diagnosed, and the timeline of public awareness of the talc litigation are all facts that determine whether your case is timely.
This is why you cannot wait. If you have been diagnosed with ovarian cancer or mesothelioma and you have a history of talc product use, the safest thing you can do is speak with a lawyer now — while the evidence is still available, while the pathology may still be preserved, and while the statute of limitations is still running in your favor. Every month you wait is a month closer to a deadline you may not be able to see.
The First Steps: What to Do If You Used Talc Products
If you used talc-based products — Johnson’s Baby Powder, Shower to Shower, or another brand — and you have been diagnosed with ovarian cancer or mesothelioma, here is what you should do, and what you should not do:
Do:
-
Preserve all product containers and packaging. If you still have any bottle, box, or container of talc powder you used, keep it. Store it in a clean, dry place. Do not open it, do not use it, do not dispose of it. That container is physical evidence that can be tested for asbestos contamination and talc composition.
-
Document your exposure history in writing. Write down everything you can remember: which brand(s) you used, how you applied it (perineal area, body, baby), how often (daily, weekly), what years you used it (as precisely as you can — “from about 1975 to about 2010”), and when and why you stopped. Include any details about where you purchased it and whether anyone else in your household used it.
-
Gather your medical records. Request complete copies of your medical records from every provider who has treated your cancer — your oncologist, your surgeon, your radiologist, the hospital where you had surgery, the lab that processed your pathology. You are entitled to your own records. Get them.
-
Ask about pathology tissue blocks. Contact the pathology department at the hospital where your surgery or biopsy was performed and ask whether tissue blocks from your procedure are still retained. If they are, that tissue can potentially be analyzed for talc particles or asbestos fibers. A lawyer’s preservation demand can freeze those blocks before the hospital’s retention schedule allows destruction.
-
Talk to family members. Ask spouses, children, siblings, and close friends whether they remember your talc use — the brand, the frequency, the duration. Their corroboration is evidence. Write down what they tell you, or better, have them write it down themselves.
-
Call a lawyer who handles talc litigation. Not a generalist. Not a firm that handles car wrecks and occasionally takes a product case. A lawyer or firm that knows the talc MDL, understands the specific causation evidence, has access to the corporate documents, and can evaluate your individual case honestly.
Do not:
-
Do not give a recorded statement to any insurance representative or claims administrator. If anyone contacts you claiming to represent Johnson & Johnson, Kenvue, or any claims fund, and asks you to describe your product use or your medical history on a recording, decline. That recording is designed to be used against you.
-
Do not sign anything. If you receive a release, a settlement offer, a waiver, or any document from Johnson & Johnson, a claims administrator, or anyone purporting to represent the company, do not sign it without having a lawyer review it first. A release signed today can extinguish your right to sue tomorrow.
-
Do not post about your case on social media. The defense monitors social media. A post about your health, your activities, your emotional state, or your legal intentions can be taken out of context and used to undermine your claim. Assume everything you post is being read by someone who is not on your side.
-
Do not wait to see what happens with the litigation. The MDL is ongoing. Verdicts go both ways. Settlements may or may not materialize. But your statute of limitations is running, and your evidence is aging. Waiting is the one decision that cannot be undone.
Frequently Asked Questions
Can I still file a talc lawsuit after a defense verdict in Los Angeles?
Yes. A defense verdict in one case does not bar other plaintiffs from filing or pursuing claims. The Los Angeles verdict was one jury’s response to one set of facts. More than 68,000 talc cases remain pending in the federal multidistrict litigation. Your right to file is governed by the statute of limitations in your state, not by the outcome of someone else’s trial.
How long do I have to file a talc claim in California?
California’s personal injury statute of limitations generally gives you two years from the date you discovered, or should have discovered, that your injury was caused by talc. For latent diseases like cancer, the discovery rule applies — the clock starts when you knew or should have known of the connection between your diagnosis and your talc use, not when you were exposed. This is a case-specific determination, and you should not assume you have time to wait.
What if I used talc products for decades — does that make my case stronger?
Generally, yes. A longer, more frequent exposure history provides a stronger foundation for specific causation — the evidence that talc was a substantial factor in causing your cancer. Daily perineal use of a specific brand for 30 years is a stronger exposure profile than occasional use of an unidentified powder for a few years. But exposure history is only one piece of the puzzle — pathology evidence, product identification, and the exclusion of alternative causes also matter.
Does the Los Angeles verdict mean juries don’t believe talc causes cancer?
No. It means one jury, on one set of specific facts, was not persuaded that the plaintiff had proven her individual case. The verdict reflects the difficulty of proving specific causation in ovarian cancer cases where general causation is scientifically contested — not a universal rejection of the talc-cancer link. Other juries, including the Ingham jury in Missouri, have reached the opposite conclusion and returned multi-billion-dollar plaintiff verdicts.
What is the difference between ovarian cancer and mesothelioma in talc cases?
Ovarian cancer cases rely on the theory that talc particles travel to the ovaries and cause inflammation that promotes cancer. The general causation science is contested. Mesothelioma cases rely on the theory that asbestos-contaminated talc delivered asbestos fibers to the user, and mesothelioma is a cancer essentially signature to asbestos exposure. Mesothelioma cases typically have stronger specific causation because the disease itself points back to the asbestos in the product.
How much is a talc lawsuit worth?
Case values across the talc litigation have ranged from $0 (defense verdicts) to approximately $2.12 billion (the affirmed Ingham verdict for 22 plaintiffs). Individual case value depends on the diagnosis type, exposure history, pathology evidence, punitive damages exposure, the plaintiff’s age and economic losses, and the jurisdiction. California has no general cap on compensatory damages in product liability cases. No lawyer can guarantee a specific outcome — past results depend on the facts of each case and do not guarantee future outcomes.
What evidence do I need for a talc case?
The key evidence categories are: your exposure history (which product, how often, how long), your medical records and diagnosis, pathology tissue blocks (if available) that can be analyzed for talc particles or asbestos fibers, any physical product containers you still have, corroborating testimony from family members, and the internal corporate documents available through the MDL discovery process. A lawyer who handles talc litigation can evaluate what evidence is available in your specific case and how to preserve it.
Should I accept a settlement offer from Johnson & Johnson?
Do not accept any settlement offer or sign any release without having a lawyer review it first. A settlement offer from the company or its claims administrator is designed to resolve your claim for the lowest amount the company believes you will accept. An offer made before you have legal representation is almost always lower than what the case is actually worth. A lawyer can evaluate whether the offer is fair, whether you should negotiate, or whether you should proceed to trial.
What if my loved one died from ovarian cancer — can I still file?
Yes. If your spouse, parent, or child died from ovarian cancer or mesothelioma and had a history of talc product use, you may have a wrongful death claim and a survival action. In California, wrongful death damages can include loss of financial support, loss of companionship, and funeral expenses. The survival action carries the decedent’s own claim for pain and suffering and medical expenses incurred prior to death. The statute of limitations for wrongful death in California is generally two years from the date of death. Our wrongful death practice page has more information.
Does it matter which brand of talc powder I used?
Yes. Product identification — proving that you used a specific brand made by a specific defendant — is a required element of a product liability claim. Johnson’s Baby Powder and Shower to Shower are the most commonly named products in the J&J talc litigation. If you used a different brand, the defendant may be a different company. If you used a generic or store brand, identifying the manufacturer may require additional investigation. The more specific you can be about the brand, the packaging, and the time period, the stronger the product identification evidence.
Why Attorney911
We are a trial firm that takes California cases, working with local counsel where required. We do not claim an office in California, and we will not pretend to something we are not. What we are is a firm with the experience, the resources, and the trial mindset to handle complex product liability and toxic tort cases — and the honesty to tell you whether your case is strong before you spend a minute worrying about the wrong things.
Ralph Manginello is our Managing Partner — his background is here. He has been licensed since November 6, 1998 — 27+ years of trial practice, including in federal court. He was a journalist before he was a lawyer, which means he knows how to find a story in a stack of documents, and he knows how to tell it to a jury. He has spent his career in courtrooms, and he does not settle cases because they are hard. He tries them because they are right.
Lupe Peña is our associate attorney — his background is here. Before he joined this firm, Lupe spent years inside a national insurance-defense firm — the rooms where adjusters and their software decide how to deny, delay, and devalue claims exactly like yours. He sat across the table from the people who would be sitting across from you. He knows how claims are valued from the inside — how reserves are set, how recorded statements are engineered, how settlement offers are calibrated to extract the maximum release for the minimum payment. Now he uses that knowledge for injured clients. He conducts full client consultations in Spanish, without an interpreter, because the language you pray in is the language you should be able to speak to your lawyer in.
We work on contingency. That means we don’t get paid unless we win your case. The consultation is free. The first conversation costs you nothing — not money, not obligation, not pressure. You can call us at 1-888-ATTY-911 — 1-888-288-9911 — 24 hours a day, 7 days a week. You will speak to a live person, not an answering service.
We have recovered more than $50 million for our clients across the cases we have handled — including a $5M+ brain-injury settlement, a $3.8M+ amputation settlement, and a $2.5M+ truck-crash recovery. Past results depend on the facts of each case and do not guarantee future outcomes. What we guarantee is this: we will tell you the truth about your case, we will tell you whether it is worth pursuing, and if it is, we will build it as hard as we know how.
Hablamos Español. Lupe conducts full consultations in Spanish. If your family communicates in Spanish, your case will be handled in the language you actually think in.
If you used talc products and received an ovarian cancer or mesothelioma diagnosis, do not let one verdict in one courtroom talk you out of finding out whether your case is different. Call us. Contact us through our website. Let us look at your specific history, your specific diagnosis, and your specific evidence — and tell you honestly whether the fight is worth it. The call is free. The answer may change everything.
1-888-ATTY-911. 24/7. Free consultation. No fee unless we win.